STOCK TITAN

Israeli Biotech PolyPid Secures Major Funding Boost from 20 Strategic Investors

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
D

Rhea-AI Filing Summary

PolyPid, an Israeli biotechnology company established over five years ago, has filed Form D to report an exempt securities offering under Rule 506(b). The company has successfully completed a $26,692,799 offering, with all securities now sold to 20 investors.

The offering includes equity securities, along with options/warrants and their underlying securities. The company, which currently reports no revenues, maintains its principal operations at 18 Hasivim Street, Petach Tikva, Israel.

Key management includes:

  • Four executive officers: Dikla Czaczkes Akselbrad, Dalit Hazan, Ori Warshavsky, and Jonny Missulawin
  • Eight independent directors including Jacob Harel, Yechezkel Barenholz, and others

The offering involves no sales commissions or finder's fees, and none of the proceeds are designated for payments to executives or directors. The offering is not connected to any business combination transaction and is not intended to last more than one year.

Positive

  • PolyPid successfully raised $26.69M through a Rule 506(b) private placement with 20 investors
  • The offering was fully subscribed with $0 remaining to be sold, indicating strong investor interest

Negative

  • Company reports no revenues, indicating pre-revenue development stage status
  • The offering is not intended to last more than one year, suggesting potential need for additional future fundraising

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM D

Notice of Exempt Offering of Securities

OMB APPROVAL
OMB Number: 3235-0076
Estimated average burden
hours per response: 4.00

1. Issuer's Identity

CIK (Filer ID Number) Previous Names
X None
Entity Type
0001611842
X Corporation
Limited Partnership
Limited Liability Company
General Partnership
Business Trust
Other (Specify)

Name of Issuer
PolyPid Ltd.
Jurisdiction of Incorporation/Organization
ISRAEL
Year of Incorporation/Organization
X Over Five Years Ago
Within Last Five Years (Specify Year)
Yet to Be Formed

2. Principal Place of Business and Contact Information

Name of Issuer
PolyPid Ltd.
Street Address 1 Street Address 2
18 HASIVIM STREET
City State/Province/Country ZIP/PostalCode Phone Number of Issuer
PETACH TIKVA ISRAEL 495376 +972-74-719-5700

3. Related Persons

Last Name First Name Middle Name
Czaczkes Akselbrad Dikla
Street Address 1 Street Address 2
18 Hasivim Street
City State/Province/Country ZIP/PostalCode
Petach Tikva ISRAEL 495376
Relationship: X Executive Officer Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Hazan Dalit
Street Address 1 Street Address 2
18 Hasivim Street
City State/Province/Country ZIP/PostalCode
Petach Tikva ISRAEL 495376
Relationship: X Executive Officer Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Warshavsky Ori
Street Address 1 Street Address 2
18 Hasivim Street
City State/Province/Country ZIP/PostalCode
Petach Tikva ISRAEL 495376
Relationship: X Executive Officer Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Missulawin Jonny
Street Address 1 Street Address 2
18 Hasivim Street
City State/Province/Country ZIP/PostalCode
Petach Tikva ISRAEL 495376
Relationship: X Executive Officer Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Harel Jacob
Street Address 1 Street Address 2
18 Hasivim Street
City State/Province/Country ZIP/PostalCode
Petach Tikva ISRAEL 495376
Relationship: Executive Officer X Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Barenholz Yechezkel
Street Address 1 Street Address 2
18 Hasivim Street
City State/Province/Country ZIP/PostalCode
Petach Tikva ISRAEL 495376
Relationship: Executive Officer X Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Dror Nir
Street Address 1 Street Address 2
18 Hasivim Street
City State/Province/Country ZIP/PostalCode
Petach Tikva ISRAEL 495376
Relationship: Executive Officer X Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
BenAmram Yossi
Street Address 1 Street Address 2
18 Hasivim Street
City State/Province/Country ZIP/PostalCode
Petach Tikva ISRAEL 495376
Relationship: Executive Officer X Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Krinsky Itzhak
Street Address 1 Street Address 2
18 Hasivim Street
City State/Province/Country ZIP/PostalCode
Petach Tikva ISRAEL 495376
Relationship: Executive Officer X Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Stein Robert B.
Street Address 1 Street Address 2
18 Hasivim Street
City State/Province/Country ZIP/PostalCode
Petach Tikva ISRAEL 495376
Relationship: Executive Officer X Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Tweezer-Zaks Nurit
Street Address 1 Street Address 2
18 Hasivim Street
City State/Province/Country ZIP/PostalCode
Petach Tikva ISRAEL 495376
Relationship: Executive Officer X Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Jacobovitz Yitzchak
Street Address 1 Street Address 2
18 Hasivim Street
City State/Province/Country ZIP/PostalCode
Petach Tikva ISRAEL 495376
Relationship: Executive Officer X Director Promoter

Clarification of Response (if Necessary):


4. Industry Group

Agriculture
Banking & Financial Services
Commercial Banking
Insurance
Investing
Investment Banking
Pooled Investment Fund
Is the issuer registered as
an investment company under
the Investment Company
Act of 1940?
Yes No
Other Banking & Financial Services
Business Services
Energy
Coal Mining
Electric Utilities
Energy Conservation
Environmental Services
Oil & Gas
Other Energy
Health Care
X Biotechnology
Health Insurance
Hospitals & Physicians
Pharmaceuticals
Other Health Care
Manufacturing
Real Estate
Commercial
Construction
REITS & Finance
Residential
Other Real Estate
Retailing
Restaurants
Technology
Computers
Telecommunications
Other Technology
Travel
Airlines & Airports
Lodging & Conventions
Tourism & Travel Services
Other Travel
Other

5. Issuer Size

Revenue Range OR Aggregate Net Asset Value Range
X No Revenues No Aggregate Net Asset Value
$1 - $1,000,000 $1 - $5,000,000
$1,000,001 - $5,000,000 $5,000,001 - $25,000,000
$5,000,001 - $25,000,000 $25,000,001 - $50,000,000
$25,000,001 - $100,000,000 $50,000,001 - $100,000,000
Over $100,000,000 Over $100,000,000
Decline to Disclose Decline to Disclose
Not Applicable Not Applicable

6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)

Rule 504(b)(1) (not (i), (ii) or (iii))
Rule 504 (b)(1)(i)
Rule 504 (b)(1)(ii)
Rule 504 (b)(1)(iii)
X Rule 506(b)
Rule 506(c)
Securities Act Section 4(a)(5)
Investment Company Act Section 3(c)
Section 3(c)(1) Section 3(c)(9)
Section 3(c)(2) Section 3(c)(10)
Section 3(c)(3) Section 3(c)(11)
Section 3(c)(4) Section 3(c)(12)
Section 3(c)(5) Section 3(c)(13)
Section 3(c)(6) Section 3(c)(14)
Section 3(c)(7)

7. Type of Filing

X New Notice Date of First Sale 2025-06-16 First Sale Yet to Occur
Amendment

8. Duration of Offering

Does the Issuer intend this offering to last more than one year?
Yes X No

9. Type(s) of Securities Offered (select all that apply)

X Equity Pooled Investment Fund Interests
Debt Tenant-in-Common Securities
X Option, Warrant or Other Right to Acquire Another Security Mineral Property Securities
X Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security Other (describe)

10. Business Combination Transaction

Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer?
Yes X No

Clarification of Response (if Necessary):

11. Minimum Investment

Minimum investment accepted from any outside investor $0 USD

12. Sales Compensation

Recipient
Recipient CRD Number X None
NONE None
(Associated) Broker or Dealer X None
(Associated) Broker or Dealer CRD Number X None
None None
Street Address 1 Street Address 2
NONE
City State/Province/Country ZIP/Postal Code
NONE Unknown 00000
State(s) of Solicitation (select all that apply)
Check "All States" or check individual States
All States
Foreign/non-US
CALIFORNIA
MARYLAND
NEW YORK
TEXAS

13. Offering and Sales Amounts

Total Offering Amount $26,692,799 USD
or Indefinite
Total Amount Sold $26,692,799 USD
Total Remaining to be Sold $0 USD
or Indefinite

Clarification of Response (if Necessary):

14. Investors

Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors, and enter the number of such non-accredited investors who already have invested in the offering.
Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering:
20

15. Sales Commissions & Finder's Fees Expenses

Provide separately the amounts of sales commissions and finders fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.

Sales Commissions $0 USD
Estimate
Finders' Fees $0 USD
Estimate

Clarification of Response (if Necessary):

16. Use of Proceeds

Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.

$0 USD
Estimate

Clarification of Response (if Necessary):

Signature and Submission

Please verify the information you have entered and review the Terms of Submission below before signing and clicking SUBMIT below to file this notice.

Terms of Submission

In submitting this notice, each issuer named above is:
  • Notifying the SEC and/or each State in which this notice is filed of the offering of securities described and undertaking to furnish them, upon written request, in the accordance with applicable law, the information furnished to offerees.*
  • Irrevocably appointing each of the Secretary of the SEC and, the Securities Administrator or other legally designated officer of the State in which the issuer maintains its principal place of business and any State in which this notice is filed, as its agents for service of process, and agreeing that these persons may accept service on its behalf, of any notice, process or pleading, and further agreeing that such service may be made by registered or certified mail, in any Federal or state action, administrative proceeding, or arbitration brought against the issuer in any place subject to the jurisdiction of the United States, if the action, proceeding or arbitration (a) arises out of any activity in connection with the offering of securities that is the subject of this notice, and (b) is founded, directly or indirectly, upon the provisions of: (i) the Securities Act of 1933, the Securities Exchange Act of 1934, the Trust Indenture Act of 1939, the Investment Company Act of 1940, or the Investment Advisers Act of 1940, or any rule or regulation under any of these statutes, or (ii) the laws of the State in which the issuer maintains its principal place of business or any State in which this notice is filed.
  • Certifying that, if the issuer is claiming a Regulation D exemption for the offering, the issuer is not disqualified from relying on Rule 504 or Rule 506 for one of the reasons stated in Rule 504(b)(3) or Rule 506(d).

Each Issuer identified above has read this notice, knows the contents to be true, and has duly caused this notice to be signed on its behalf by the undersigned duly authorized person.

For signature, type in the signer's name or other letters or characters adopted or authorized as the signer's signature.

Issuer Signature Name of Signer Title Date
PolyPid Ltd. /s/ Jonny Missulawin Jonny Missulawin Chief Financial Officer 2025-06-23

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.

* This undertaking does not affect any limits Section 102(a) of the National Securities Markets Improvement Act of 1996 ("NSMIA") [Pub. L. No. 104-290, 110 Stat. 3416 (Oct. 11, 1996)] imposes on the ability of States to require information. As a result, if the securities that are the subject of this Form D are "covered securities" for purposes of NSMIA, whether in all instances or due to the nature of the offering that is the subject of this Form D, States cannot routinely require offering materials under this undertaking or otherwise and can require offering materials only to the extent NSMIA permits them to do so under NSMIA's preservation of their anti-fraud authority.


FAQ

What type of securities offering did PYPD file on June 28, 2025?

PYPD filed a Form D for an exempt securities offering under Rule 506(b) of Regulation D. The offering included equity securities, options/warrants, and securities to be acquired upon exercise of those rights.

How much did PYPD raise in their June 2025 private placement?

PYPD raised $26,692,799 in total proceeds from the offering, with the entire amount being sold to investors, leaving $0 remaining to be sold.

How many investors participated in PYPD's June 2025 private placement?

According to the Form D filing, a total of 20 investors participated in PYPD's private placement offering.

What is PYPD's current revenue status as disclosed in the Form D?

PYPD indicated in the Form D that it currently has 'No Revenues' in its revenue range disclosure.

In which states did PYPD offer these securities?

PYPD offered the securities in four U.S. states: California, Maryland, New York, and Texas.
Polypid Ltd.

NASDAQ:PYPD

View PYPD Stock Overview

PYPD Rankings

PYPD Latest News

PYPD Latest SEC Filings

PYPD Stock Data

79.58M
15.32M
Biotechnology
Healthcare
Link
Israel
Petah Tikva